MedPath

Systematized Quality Exercise Alternatives for Stress Incontinence

Not Applicable
Completed
Conditions
Pelvic Floor; Weak
Quality of Life
Incontinence, Urinary
Stress Urinary Incontinence
Registration Number
NCT03443687
Lead Sponsor
University of New Mexico
Brief Summary

This randomized controlled study evaluates the effect of home biofeedback compared to pelvic floor physical therapy for the treatment of stress urinary incontinence. Half of the participants will use a home biofeedback device for 3 months and the other half will attend pelvic floor physical therapy appointments for 3 months.

Detailed Description

Biofeedback has been shown to be highly effective the treatment of stress urinary incontinence when used in conjunction with pelvic floor physical therapy under the instruction of a healthcare provider. Home biofeedback has not been well studied, even though several FDA cleared devices are on the market and available for patients to purchase. It is unclear if the biofeedback improves women's urinary incontinence, or if the increased contact with a healthcare provider causes the improvement.

Using a home biofeedback device, a woman places the device in her vagina and contracts the muscles of her pelvic floor to improve the strength, which can improve or cure incontinence when performed over time. Typically it takes 3 months for benefit to be seen.

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
54
Inclusion Criteria
  • Female Subjects >18 years of age
  • SUI or Mixed UI with stress predominant symptoms and more bother by the SUI
  • English speaking/reading
  • Own a smartphone that can support phone application and Bluetooth for the biofeedback device
  • Willing to come for 4 PFPT visits over 3 months if randomized
Exclusion Criteria
  • Prior anti-incontinence surgery
  • Had prior pelvic floor physical therapy for SUI
  • Prolapse of any compartment noted below the hymen
  • Inability to speak/understand English
  • Pregnant
  • Decline or unable to return for frequent PT visits during study period
  • Unable to be contacted for follow up by telephone
  • Neurologic disorders known to cause neurogenic bladder

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change in Quality of Life3 months

Scale is International Consultation Incontinence Questionnaire short form (ICIQ-SF). Minimum is 0 and Maximum is 21. A higher score indicates greater impairment from incontinence.

Secondary Outcome Measures
NameTimeMethod
Sexual Function3 Months

Female sexual index will be used to assess change in sexual function over study. Female sexual function index (FSFI) questionnaire and Pelvic organ prolapse incontinence sexual questionnaire were PI developed questionnaires. The minimum is 0 and the maximum is 36. A higher score indicates greater sexual impairment.

Trial Locations

Locations (1)

University of New Mexico

🇺🇸

Albuquerque, New Mexico, United States

University of New Mexico
🇺🇸Albuquerque, New Mexico, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.